| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Methotrexate | FAERS: 11 | US FAERS | |
| 2 | Ruxolitinib phosphate | FAERS: 6 | US FAERS | |
| 3 | Imatinib Mesylate | FAERS: 5 | US FAERS | |
| 4 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 4 | US FAERS | |
| 5 | Risperidone | FAERS: 4 | OFFSIDES US FAERS | |
| 6 | Valproic Acid | FAERS: 4 | US FAERS | |
| 7 | Capecitabine | FAERS: 3 | US FAERS | |
| 8 | Paroxetine | FAERS: 3 | US FAERS | |
| 9 | Atomoxetine Hydrochloride | FAERS: 2 | US FAERS | |
| 10 | Carbamazepine | FAERS: 2 | US FAERS | |
| 11 | Fingolimod Hydrochloride | FAERS: 2 | US FAERS | |
| 12 | Linezolid | FAERS: 2 | US FAERS | |
| 13 | Lopinavir | FAERS: 2 | US FAERS | |
| 14 | Olanzapine | FAERS: 2 | US FAERS | |
| 15 | Omeprazole | FAERS: 2 | US FAERS | |
| 16 | Tacrolimus | FAERS: 2 | US FAERS | |
| 17 | Tazocilline | FAERS: 2 | US FAERS | |
| 18 | apixaban | FAERS: 2 | US FAERS | |
| 19 | gemcitabine | FAERS: 2 | US FAERS | |
| 20 | Albendazole | FAERS: 1 | US FAERS | |
| 21 | Azathioprine | FAERS: 1 | US FAERS | |
| 22 | Carboplatin | FAERS: 1 | US FAERS | |
| 23 | Cisplatin | FAERS: 1 | US FAERS | |
| 24 | Diazoxide | FAERS: 1 | US FAERS | |
| 25 | Everolimus | FAERS: 1 | US FAERS | |
| 26 | Gefitinib | FAERS: 1 | US FAERS | |
| 27 | Hydroxyzine | FAERS: 1 | US FAERS | |
| 28 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 29 | Lamotrigine | FAERS: 1 | US FAERS | |
| 30 | Methotrexate | FAERS: 1 | US FAERS | |
| 31 | Methylprednisolone Hemisuccinate | FAERS: 1 | US FAERS | |
| 32 | Phenytoin | FAERS: 1 | OFFSIDES US FAERS | |
| 33 | Probenecid and colchicine | FAERS: 1 | US FAERS | |
| 34 | Quetiapine Fumarate | FAERS: 1 | US FAERS | |
| 35 | Sirolimus | FAERS: 1 | US FAERS | |
| 36 | Sofosbuvir | FAERS: 1 | US FAERS | |
| 37 | Sulfasalazine | FAERS: 1 | US FAERS | |
| 38 | Tadalafil | FAERS: 1 | US FAERS | |
| 39 | Valproic Acid | FAERS: 1 | US FAERS | |
| 40 | Zoledronic Acid | FAERS: 1 | US FAERS | |
| 41 | carfilzomib | FAERS: 1 | US FAERS | |
| 42 | lenvatinib | FAERS: 1 | US FAERS | |
| 43 | ponatinib | FAERS: 1 | US FAERS | |
| 44 | teriflunomide | FAERS: 1 | US FAERS | |
| 45 | Acetylcysteine | OFFSIDES | ||
| 46 | Alendronate | OFFSIDES | ||
| 47 | Bortezomib | OFFSIDES | ||
| 48 | Clozapine | Canada Vigilance: 1 | Canada Vigilance | |
| 49 | Dapsone | OFFSIDES | ||
| 50 | Darunavir | OFFSIDES | ||
| 51 | Diclofenac | OFFSIDES | ||
| 52 | Digitoxin | OFFSIDES | ||
| 53 | Dioctyl Sulfosuccinic Acid | OFFSIDES | ||
| 54 | Doxycycline | OFFSIDES | ||
| 55 | Fluvoxamine | OFFSIDES | ||
| 56 | Ganciclovir | OFFSIDES | ||
| 57 | Hydroxyurea | OFFSIDES | ||
| 58 | Imipenem | OFFSIDES | ||
| 59 | Lamivudine | OFFSIDES | ||
| 60 | Medroxyprogesterone Acetate | OFFSIDES | ||
| 61 | Medroxyprogesterone | OFFSIDES | ||
| 62 | Methocarbamol | OFFSIDES | ||
| 63 | Nafronyl | OFFSIDES | ||
| 64 | Niacin | OFFSIDES | ||
| 65 | Perindopril | OFFSIDES | ||
| 66 | Piperacillin, Tazobactam Drug Combination | OFFSIDES | ||
| 67 | Rabeprazole | SIDER | ||
| 68 | Rifampin | OFFSIDES | ||
| 69 | Rilmenidine | OFFSIDES | ||
| 70 | Rivastigmine | OFFSIDES | ||
| 71 | Stavudine | OFFSIDES | ||
| 72 | Tazobactam | OFFSIDES | ||
| 73 | Tenofovir | OFFSIDES | ||
| 74 | Terbinafine | OFFSIDES | ||
| 75 | Trichlormethiazide | OFFSIDES | ||
| 76 | Vitamin D | OFFSIDES | ||
| 77 | Voriconazole | OFFSIDES | ||
| 78 | Zidovudine | OFFSIDES | ||
| 79 | acemetacin | OFFSIDES | ||
| 80 | acetaminophen, dextropropoxyphene, drug combination | OFFSIDES | ||
| 81 | benfluorex | OFFSIDES | ||
| 82 | distigmine | OFFSIDES | ||
| 83 | isoniazid, pyrazinamide, rifampin drug combination | OFFSIDES | ||
| 84 | naftopidil | OFFSIDES | ||
| 85 | tipranavir | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.